Gerard van Hamel Platerink
Managing Director

Gerard helped to co-found AMV in 2003.  Prior to joining AMV, Gerard worked at Novoste Corporation, the cardiovascular brachytherapy company, in business development and corporate communications. Before joining Novoste, Gerard was an equity research analyst with Salomon Brothers (now Citigroup) in London, where he focused on the medical device sector.

Gerard began his career with Kleinwort Benson, where he was an investment banker and member of the bank's private equity and mezzanine finance group. Gerard is a Dutch national, was born in Borneo in Southeast Asia, grew up in Africa and was educated in the UK where he got his BS in Physics from St. Andrews University and an MBA from Cambridge University.

Gerard is the founder of Halscion (funded by Versant Ventures, SV Life Sciences and AMV) and Sebacia (funded by Versant Ventures, Domain Associates and AMV) and currently has board responsibilities for Halscion, Sebacia, Axogen, Neuronetics and CardioFocus.